PTU - Polskie Towarzystwo Urologiczne
home page
current numbers
archival numbers
list of articles:
list przewodni/covering letter
editor
Scientific Committee
publisher
subscription
advertising
important links

THE RESULTS OF URINARY BLADDER NEOPLASMS MANAGEMENT BY TRANSURETHRAL RESECTION AND NEODYMIUM YAG LASER
Article published in Urologia Polska 1998/51/2.

authors

Krzysztof Bar
I Katedra i Klinika Urologii ¦l±skiej AM w Katowicach
Kierownik: dr hab. n. med. A. Preisner

keywords

urinary bladder neoplasm treatment Nd:YAG laser

summary

Objective. Results of treatment urinary bladder neoplasms (UBN) by
transurethral resection and neodymium YAG laser.
Material and method. Using endoscopic procedures we treated 142
patients with urinary bladder neoplasm. The age range of the patients was
from 17 to 83 years (mean age 60 ? 12 years). In the analized group there
were 107 men and 35 women; the group was divided into three subgroups:
first ? 72 patients treated by transurethral tumor resection (TURT), second
? 44 patients treated by combined TURT + FTL (photoradiation laser),
and the third ? 26 patients treated by FTL monotherapy. Observation time
ranged from 6 to 80 months.
Results. The incidance of UBN recurrence was significantly higher in the
FTL subgroup when compared to the TURT and TURT + FTL subgroups. The
highest recurrence rate (rr) UBN was observed in the subgroup treated by
FTL monotherapy, and the lowest in the TURT + FTL subgroup. In the FTL
subgroup the incidence of both recurrent tumours and the UBN recurrence
was significantly higher than in the remaining subgroup.
Conclusion. 1. The best results of UBN treatment were achieved in
combined endoscopic procedure TURT + FTL. 2. The orthotopic tumor
recurrence is not related to the type of endoscopic procedure. 3. The lowest
percentage of heterotopic tumor recurrence was found in patients treated by
TURT + FTL. The fre±uency of tumor recurrence depends on the character of
UBN (especially polychronotopic) rather than on the type of endoscopic
procedure used.

references

  1. [1] Abel, RD.: Follow-up of patients with ?superficial" transitional cell carcinoma of
  2. the bladder: the case for a change in policy. Br. J. Urol. 1993, 72,135-142.
  3. [2] Abel, T.-D., Hall, R. R., Williams, G.: Should pT^ transitional cell cancers of the
  4. bladder still be classified as superficial? Br. J. Urol. 1988, 62, 235-239.
  5. [3] Bar, K., Preisner, A., Kawecki, J.: Laseru) leczeniu niektórych guzów pęcherza
  6. moczowego (doniesienie wstępne). Urol. Pol. 1990,43,170-173.
  7. [4] Beer, M., Jocham, D., Beer, A., Staehler, G.: Adjuvant laser treatment of
  8. bladder cancer: 8 years' experience with the Nd:YAG laser 1064 nm. Br. J. Urol. 1989,
  9. 63, 476-478.
  10. [5] Beisland, H. O., Sander, S.: Neodymium-YAG laser irradiation of stage T2 muscle-
  11. -invasive bladder cancer. Long-term results. Br. J. Urol. 1990,65,24-26.
  12. [6] Beisland, H. O., Seland, R: A prospectine randomized study on neodymium-
  13. -YAG laser irradiation versus TUR in the treatment of urinary bladder cancer. Scand.
  14. J. Urol. Nephrol. 1985, 20, 209-212.
  15. [7] Bishop, M.C: Diagnostic procedures, [w:] Bladder cancer, red. E. J. Zingg, D. M. A.
  16. Wallace. Springer Verlag, Berlin, Heidelberg 1985,87-115.
  17. [8] Borkowski, A.: Leczenie powierzchownych nowotworów pęcherza moczowego, [w:]
  18. Urologia' 89. Oddział Warszawski PTU, Warszawa 1990.
  19. [9] Chisholm, G. D., Hindmarsh, J. R., Howatson, A. G., Webb, J. N., Busut-
  20. til A., Hargreave, T. B., Newsam, J. E.: TNM (1978) in bladder cancer: use and
  21. abuse. Br. J. Urol. 1980, 52,500-505.
  22. [10] Cummings, K. B.: Diagnosis, staging, and classification of bladder tumors.
  23. Semin. Urol. 1983,1, 7-14.
  24. [11] Fitzpatrick, J. M., West, A. B., Butler, M. R., Lane, V., OTlynn, J. D.:
  25. Superficial bladder tumors (stage pT,,, grades 1 and 2): the importance of recurrence
  26. pattern following initial resection. J. Urol. 1986,135, 920-922.
  27. [12] Flamm, J., Steiner, R.: Stellenwert der differenzierten transurethralen Resection
  28. beim primdren oberflachlichen Hamblasenkarzinom. Urologe A 1990,30,111-113.
  29. [13] Gilbert, H. A., Logan, J. L., Kagan, A. R., Friedman, H. A., Cove, J. K.,
  30. Fox, M., Muldoon, T. M., Lonni, Y. W., Rowe, J. H., Cooper, J. F., Nuss-
  31. baum, H., Chan, R, Rao, A., Starr, A.: The natural history of papillary transi-
  32. tional cell carcinoma of the bladder and its treatment in an unselected population on
  33. the basis of histologic grading. J. Urol. 1978,119, 488-492.
  34. [14] Hargreave, T. B.: Carcinoma in situ. [w:] Bladder cancer, red. E. J. Zingg, D. M. A.
  35. Wallace. Springer Verlag, Berlin, Heidelberg 1985,141-159.
  36. [15] Heney, N. M., Ahmed, S., Flanagan, M. ]., Frabble, W., Corder, M. R,
  37. Hafermann, M. D., Hawkins, I. R.: Superficial bladder cancer: progression and
  38. recurrence. J. Urol. 1983,130,1083-1086.
  39. [16] Hofstetter, A., Frank B.: Neodymium:YAG laser in urology. Med. Focus 1984,3,
  40. 2-6.
  41. [17] Hofstetter, A., Schmeller, N.: DieAnwendung der Neodym-YAG-Lasers in der
  42. Urologie. Laser, 1986, 2, 98-100.
  43. [18] Hofstetter, A.: Treatment of urological tumors byNeodymium-YAG-laser. Eur. Urol.
  44. 1986,12 (supL-l), 21-24.
  45. [19] Jacobi, G. H., Engelmann, U., Hohenfellner, R.: Classification of bladder
  46. tumours, [w:] Bladder cancer, red. E. J. Zingg, D. M. A. Wallace. Springer Verlag,
  47. Berlin, Heidelberg 1985,117-139.
  48. [20] Klan, R., Loy, V., Huland, H.: Residual tumor discovered in routine second
  49. transurethral resection in patients with stage T1 transitional cell carcinoma of the
  50. bladder. J. Urol. 1991,146, 316-318.
  51. [21] Kolozsy, Z.: Histopathological ?self control" in transurethral resection of bladder
  52. tumours. Br. J. Urol. 1991,67,162-164.
  53. [22] Soloway, M. S.: Surgery and intravesical chemotherapy in the mangement of super-
  54. ficial bladder cancer. Semin. Urol. 1983,1, 23-33.
  55. [23] Williams, J. L., Hammonds, J. C, Saunders, N.: T1 bladder tumours. Br. J. Urol.
  56. 1977, 49, 663-668.
  57. [24] Zingg, E. ]., Wallace, D. M. A.: The treatment of superficial bladder tumours.
  58. [w:] Bladder cancer, red. E. J. Zingg, D. M. A. Wallace. Springer Verlag, Berlin,
  59. Heidelberg 1985,161-187.